CLINICAL_TRIALS
trial_result
· 2021-01-12
Clinical Trial Update: Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease [Phase 2]
Summary
Phase 2 trial update for aztreonam aerosol in cystic fibrosis nasal disease was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Virginia Commonwealth University | Conditions: Cystic Fibrosis | Phase 2 | Status: TERMINATED | Results posted: 2021-01-12